ANTX AN2 Therapeutics

Watchlist

1.390
-0.050-3.47%

Close Mar 28 16:00 ET

1.390
0.0000.00%

Post 20:01 ET

41.84MMarket Cap-0.81P/E (TTM)

About AN2 Therapeutics Company

AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley and is headquartered in Menlo Park, CA.

Company Profile

SymbolANTX

Company NameAN2 Therapeutics

Listing DateMar 25, 2022

Issue Price15.00

Founded2017

CEOMr. Eric Easom

MarketNASDAQ

Employees22

Fiscal Year Ends12-31

Address1800 El Camino Real,Suite D

CityMenlo Park

ProvinceCalifornia

CountryUnited States of America

Zip Code94027

Phone1-650-331-9090

Websitehttp://www.an2therapeutics.com

Company Executives

Name
Position
Salary

Eric Easom
Chairman of the Board, Chief Executive Officer and President
3.34M

Kevin Krause
Chief Strategy Officer
--

Dr. Sanjay Chanda, PhD
Chief Development Officer
--

Joshua M. Eizen, J.D.
Chief Legal Officer and Chief Operating Officer
--

Lucy O. Day
Chief Financial Officer and Principal Accounting Officer
1.52M

Stephanie Wong
Independent Director
157.14K

Patricia Martin
Independent Director
153.14K

Margaret M. FitzPatrick, M.A.
Lead Independent Director
142.14K

Kabeer Aziz
Independent Director
145.64K

Joseph S. Zakrzewski
Independent Director
179.64K

Gilbert Lynn Marks
Independent Director
145.64K

Dr. Rob Readnour, PhD
Independent Director
146.14K

Dr. Melvin K. Spigelman,M.D.
Independent Director
145.64K

ANTX AN2 Therapeutics

About AN2 Therapeutics Company

Company Profile

Company Executives

Market Insights